Pharmaceutical Technology1h
Blood cancers dominate CAR-T pipeline
Among the 13 CAR-T therapeutics that have received regulatory approval are Gilead’s Yescarta and Immuneel Therapeutics’ ...
Experimental treatment borrowed from blood cancer shows promise for pediatric brain tumors
In an early-stage clinical trial, the therapy nearly doubled the expected survival time of young patients. Still, experts ...
Express Healthcare23h
Cellogen Therapeutics secures patent for India’s first Bi-Specific CAR T Cell therapy
Cellogen Therapeutics’ CAR T cell technology introduces a bi-specific approach to cancer immunotherapy. Unlike conventional ...
News Medical on MSN14h
Childhood Brain Cancer Diagnosis Boost Via Immune Study
Researchers and pediatric neurosurgeons at the University of Pittsburgh School of Medicine and UPMC Children's Hospital of ...
SHINE19h
New Zealand woman in Shanghai for cancer treatment
A 36-year-old woman from New Zealand is being treated for cancer in Shanghai after around 3,000 people donated money to ...
Classifying childhood brain cancers by immune response may improve diagnostics and treatments
Researchers and pediatric neurosurgeons at the University of Pittsburgh School of Medicine and UPMC Children's Hospital of ...
The Hearty Soul on MSN19h
'Eureka moment' after scientists discover aspirin could help stop cancers spreading but it comes with a warning
In a remarkable scientific breakthrough that researchers are calling a ‘eureka moment,’ a team at the University of Cambridge ...
University of Chicago News21h
Researchers uncover a surprising new way the immune system ‘remembers’
The researchers next showed that when macrophages were exposed to inflammatory signals, their activity changed alongside ...
New understanding of B cell mutation strategies could have implications for vaccines
A vaccine's ability to generate long-lasting, high-affinity antibodies hinges on a delicate balance. Upon exposure to a ...
Scoring system helps predict risk of developing cancer from common blood disorder in older adults
A team of international scientists has developed a method to predict the risk of developing cancer from a blood disorder common in older adults, according to a study published in the journal Blood.
News-Medical.Net on MSN16h
Study reveals how B cells safeguard high-affinity antibodies
A vaccine's ability to generate long-lasting, high-affinity antibodies hinges on a delicate balance. Upon exposure to a vaccine or pathogen, B cells scramble to refine their defenses, rapidly mutating ...